Michael Charlton1. Show Affiliations » 1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA. charlton.michael@mayo.edu
Abstract
Entities: Disease
Mesh: See more » Antiviral Agents/therapeutic useGraft Rejection/immunologyHepatitis C/drug therapyHepatitis C/prevention & controlHepatitis C/surgeryHumansImmunocompetenceInterferon alpha-2Interferon-alpha/therapeutic useLiver TransplantationPolyethylene Glycols/therapeutic usePostoperative Complications/prevention & controlPostoperative PeriodRecombinant ProteinsSecondary Prevention
Substances: See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene Glycolspeginterferon alfa-2a
Year: 2002 PMID: 12362299 DOI: 10.1053/jlts.2002.35859
Source DB: PubMed Journal: Liver Transpl ISSN: 1527-6465 Impact factor: 5.799